Kinasen und Phosphatasen: Schlüsselenzyme in der gezielten Krebstherapie

Schlüsselwörter

Gezielte Krebstherapie - Phosphorylierung - Kinasen - Phosphatasen

Keywords

targeted cancer therapy - phosphorylation - kinases - phosphatases

• Literatur

• 1 Bollen M, Peti W, Ragusa MJ et al. The extended PP1 toolkit: designed to create specificity. Trends Biochem Sci 2010; 35: 450-458
• 2 Cook PJ, Ju BG, Telese F et al. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009; 458: 591-596
• 3 Galluzzi L, Vitale I, Senovilla L et al. Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer. Cell Rep 2012; 2: 257-269
• 4 Gohla A, Birkenfeld J, Bokoch GM. Chronophin, a novel HAD-type serine protein phosphatase, regulates cofilin-dependent actin dynamics. Nat Cell Biol 2005; 7: 21-29
• 5 Julien SG, Dube N, Hardy S et al. Inside the human cancer tyrosine phosphatome. Nat Rev Cancer 2011; 11: 35-49
• 6 Olsen JV, Blagoev B, Gnad F et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127: 635-648
• 7 Possemato R, Marks KM, Shaul YD et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476: 346-350
• 8 Sefton BM, Hunter T, Beemon K et al. Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 1980; 20: 807-816
• 9 Seifried A, Schultz J, Gohla A. Human HAD phosphatases: structure, mechanism, and roles in health and disease. FEBS J 2012; doi:
• 10 Tadjuidje E, Wang TS, Pandey RN et al. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone. PLoS One 2012; 7: e34806
• 11 Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006; 7: 833-846
• 12 Tonks NK, Diltz CD, Fischer EH. Purification of the major protein-tyrosine-phosphatases of human placenta. J Biol Chem 1988; 263: 6722-6730
• 13 Vintonyak VV, Antonchick AP, Rauh D et al. The therapeutic potential of phosphatase inhibitors. Curr Opin Chem Biol 2009; 13: 272-283
• 14 Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674